Insider · CIK 0001821353
David Dornan
officer
Files at WHWK (Whitehawk Therapeutics, Inc.), ELEV (Elevation Oncology, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +85,887 | $0.00 | $0 | 85,887 | 24 d ago |
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +85,887 | $0.00 | $0 | 85,887 | 24 d ago |
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +85,887 | $0.00 | $0 | 85,887 | 27 d ago |
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +85,887 | $0.00 | $0 | 85,887 | 27 d ago |
| Mar 4, 2025 | WHWK Whitehawk Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +687,979 | $0.00 | $0 | 687,979 | Mar 4, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Common Stock | +9,375 | - | - | 9,375 | Feb 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | FTax withholding Common Stock | -4,152 | $0.67 | $2,789 | 5,223 | Feb 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Restricted Stock Unitderivative | -9,375 | $0.00 | $0 | 28,125 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.